Find Academic Supervisors

Guoyao Wu is a Distinguished Professor of Animal Nutrition at Texas A&M University's College of Agriculture & Life Sciences, holding dual appointments in the Department of Animal Science and the Graduate Faculty of Nutrition. His expertise spans nutritional biochemistry, protein metabolism, and reproductive physiology. Dr. Wu earned his B.Sc. from South China Agricultural University, M.Sc. degrees from Beijing Agricultural University and the University of Alberta, and a Ph.D. from the University of Alberta, followed by postdoctoral training at McGill University and Memorial University of Newfoundland. His research focuses on amino acid and protein metabolism across molecular, cellular, and whole-animal levels, using models like cattle, pigs, and aquatic species. Key areas include placental nutrient transport, fetal programming, and the role of amino acids in mitigating conditions like sarcopenia and intrauterine growth restriction. He has pioneered studies on glycine, creatine, and citrulline supplementation in livestock and aquaculture. Dr. Wu has received over 15 prestigious awards from China, Canada, and the U.S., including the Thousand-People-Talent Award and Changjiang Scholar Award. He serves on editorial boards of journals like Amino Acids and Frontiers in Bioscience , and teaches graduate courses in protein metabolism. His work bridges basic science and applied nutrition, with implications for improving livestock productivity, human health, and aquaculture sustainability. Current projects address amino acid requirements of companion animals, microgravity effects on metabolism, and placental biology in ruminants.

• Animal Nutrition
• Protein and Amino Acid Metabolism
• Nutritional Biochemistry
• +5 more

Finlay Maguire is an Assistant Professor jointly appointed in the Faculty of Computer Science and the Department of Community Health & Epidemiology at Dalhousie University. He leads the Maguire Lab, which develops data-driven methods to address health and social crises through genomic epidemiology and interdisciplinary health data science. He is also affiliated with the Shared Hospital Laboratory, Sunnybrook Research Institute, and multiple national and international public health consortia including PHA4GE, CanCOGeN, and IRIDA. PhD: University College London / Natural History Museum (2016) MA: University of Oxford (2011) Donald Hill Family Fellowship, Dalhousie University (2021) Dr. Maguire's research focuses on two main areas: genomic epidemiology of infectious diseases and interdisciplinary health data science collaborations . His work in genomic epidemiology includes developing bioinformatics and machine learning tools to study antimicrobial resistance (AMR) and SARS-CoV-2 dynamics, often in collaboration with public health agencies. His broader health data science work addresses issues such as online radicalization, healthcare access for refugees, and autism-related language use, combining computational methods with social science. His recent publications (2023–2025) reflect a strong trend in pathogen genomics , AMR , zoonotic spillover , and computational social science . He has published on novel coronaviruses in bats, SARS-CoV-2 animal models, invasive Group A Streptococcus, and sociological analyses of incel communities. Much of this work involves tool development (e.g., ArgNorm, Pathoplexus) and data standardization (e.g., PHA4GE metadata standards). Finalist, 2024 Discovery Awards (Emerging Professional) 2023 President’s Research Excellence Award for an Emerging Investigator, Dalhousie Finalist, 2023 Discovery Awards (Emerging Professional) Funding from CIHR, NSERC, Genome Canada, SSHRC, BMGF Dr. Maguire actively mentors graduate students and postdocs, including PhD candidates in Computer Science and MSc students in Community Health & Epidemiology. He has secured major training grants such as the CIHR Health Research Training Platform and the Canadian One Health Training Program for Emerging Zoonoses. He also contributes to capacity-building initiatives like MicroResearch in Ghana and Kenya. The Maguire Lab is embedded in a rich network of collaborations, including the CARD database, Public Health Agency of Canada, Canadian Food Inspection Agency, and Sunnybrook Health Sciences Centre. The lab emphasizes open science, reproducible research, and interdisciplinary training, as seen in the development of open-source tools and participation in international consortia.

• Genomic Epidemiology
• Health Data Science
• Bioinformatics
• +7 more

Karsten Borgwardt is a Professor and Director of the Department of Machine Learning and Systems Biology at the Max Planck Institute of Biochemistry. He holds a PhD in Computer Science (2007) from LMU Munich and has held academic positions at ETH Zürich, Universität Tübingen, and the Max Planck Institutes in Tübingen. His research focuses on machine learning applications in biology and medicine, including biomarker discovery, personalized medicine, and systems biology. Education: PhD in Computer Science (2007), LMU Munich M.Sc. in Biology (2003), University of Oxford Diplom (M.Sc. equivalent) in Computer Science (2004), LMU Munich Research Interests: Development of machine learning algorithms for large biomedical datasets Pattern recognition in genomic and clinical data Applications in sepsis biomarkers, antimicrobial resistance prediction, and personalized medicine Grants & Projects: Scientific Coordinator of Marie Curie Networks (2013-2022) Swiss National Science Foundation Starting Grant (2014) Personalized Swiss Sepsis Study (CHF 5.3M, 2018) Awards: Krupp Award (2013), Golden Owl Teaching Award (2017), multiple 'Top 40 under 40' recognitions (2014-2016). Labs: Leads the Machine Learning and Systems Biology Department at MPI, collaborating with 22+ labs in sepsis research and international networks.

• Machine Learning
• Systems Biology
• Bioinformatics
• +3 more

Professor Urs Jenal is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he has led research on bacterial signal transduction since 2008. His laboratory investigates the molecular mechanisms of bacterial persistence and antibiotic resistance, with particular focus on pathogens causing chronic infections in humans. Previously, he served as Associate Professor (2002-2008) and Assistant Professor (1996-2002) at the same institution, and completed postdoctoral training at Stanford University and ETH Zurich. Education 2000: Habilitation and VENIA DOCENDI in Microbiology, University of Basel 1987-1991: PhD in Molecular Microbiology, ETH Zurich (supervisor: Prof. T. Leisinger) 1982-1986: Studies of Experimental Biology, ETH Zurich 1977-1981: Gymnasium with Matura Type C, Chur Research Focus Prof. Jenal's research centers on understanding how bacterial pathogens persist in the human body despite antibiotic treatments. His laboratory investigates cyclic nucleotides, particularly c-di-GMP, as signaling molecules that control bacterial biofilm formation, virulence, and antibiotic tolerance. His team studies pathogenic Escherichia coli causing recurrent urinary tract infections and Pseudomonas aeruginosa causing long-term lung infections in cystic fibrosis patients. Recent work has revealed how "sleeping" bacteria survive antibiotic treatments and how pathogens breach respiratory epithelia through goblet cell invasion. Scientific Recognition 2014: Elected member of the European Academy of Microbiology (EAM) 2013: ERC Advanced Investigator Award 2012: Elected member of the European Molecular Biology Organization (EMBO) 2011: Elected member of the American Academy of Microbiology (AAM) Mentorship and Collaborations Prof. Jenal has mentored numerous PhD students and postdocs, many receiving awards for their research. His laboratory is part of the NCCR AntiResist initiative focused on developing novel approaches against antibiotic resistance. He collaborates extensively with clinical researchers and has developed innovative models, including human mini-lungs, to investigate pathogen-host interactions. His recent publications demonstrate how understanding bacterial persistence mechanisms can lead to new therapeutic strategies against chronic infections.

• Bacterial Signal Transduction
• Microbiology
• Antibiotic Resistance
• +5 more

Karl Griswold is a Professor of Engineering at Dartmouth College's Thayer School of Engineering, where he leads the Griswold Research Group focused on protein engineering and biotherapeutics development. His interdisciplinary work spans chemical, biological, and engineering disciplines to address critical challenges in drug-resistant infections and protein therapeutics. Education: BS in Chemistry from Southwest Texas State University (1995) PhD in Chemistry from the University of Texas at Austin (2005) Research Focus: Professor Griswold's laboratory specializes in protein engineering, directed evolution, and biotherapeutics development , creating novel biomolecules with superior functionality compared to natural proteins. The group develops high-throughput screening methods, protein deimmunization strategies, enhanced expression systems, and antibacterial agents targeting drug-resistant infections. Their work has significant translational potential for treating conditions like MRSA and Pseudomonas aeruginosa infections. Scientific Recognition: Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering (2008) NIH Biotechnology Training Grant (2000-2003) Royston M. Roberts - Regents Fellowship, University of Texas (1999) DOW Chemical Foundation Scholar, Texas State University (1991-1995) Senior Fellow, National Academy of Inventors Research Leadership: As co-founder and CEO of Stealth Biologics, Professor Griswold translates academic research into commercial applications. His work has secured NIH funding and Dartmouth Innovations Accelerator support, with research featured in Chemical & Engineering News, Vermont Public Radio, and the New Hampshire Union Leader for developing alternatives to traditional antibiotics. Research Environment: The Griswold Research Group maintains extensive collaborations across disciplines including clinical medicine, immunology, structural biology, and chemical engineering. This interdisciplinary approach prepares trainees for careers at the intersection of multiple scientific fields, with research focusing on Biomolecular Antimicrobial Therapies, Deimmunizing Protein Therapeutics, and Gene Library Construction Technologies.

• Protein engineering
• Directed evolution
• Biotherapeutics
• +2 more

Karoline Faust is an Associate Professor at KU Leuven, affiliated with the Laboratory of Molecular Bacteriology (Rega Institute) and the Faculty of Medicine . She contributes to the iSi Health and Leuven One Health institutes, and serves on senior academic councils. Her research spans microbial systems biology, focusing on community dynamics and network analysis. Education: PhD in bioinformatics (2010, KU Leuven) Affiliations: KU Leuven, ISME Journal editorial board, Belgian Society for Microbiology Her research investigates microbial community dynamics , systems biology approaches to microbiomes, and bioinformatics tool development . She specializes in modeling human gut microbiota , synthetic microbial communities , and environmental microbiomes (e.g., microplastic impacts on Daphnia microbiomes). Her work integrates metabolic modeling , network analysis , and experimental systems to understand microbial interactions. Recent publications highlight her contributions to microbial network inference , 16S rRNA sequencing protocols , microfluidics , and ecological modeling of microbiomes. She develops tools like manta , miaSim , and CoNet to analyze community structures. Teaching: Karoline co-teaches courses in microbiology, bioinformatics, and network analysis at KU Leuven, and has contributed to international workshops on microbial network inference. Scientific Engagement: She serves as Senior Editor at ISME Journal and Secretary of the Belgian Society for Microbiology .

• Microbial community dynamics
• Microbial systems biology
• Bioinformatics
• +6 more

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +12 more

David Blair is a Professor at James Cook University, specializing in parasitic flatworms, molecular systematics, and evolutionary biology. His research focuses on understanding the genetic diversity, phylogeography, and host-parasite interactions of species such as Schistosoma, Paragonimus, and Opisthorchis. He has contributed extensively to studies on the molecular evolution of parasitic organisms and their implications for human and wildlife health. Key research areas include: molecular taxonomy of trematodes, phylogenetic analysis of parasitic flatworms, and genomic studies of host-parasite coevolution. Collaborations span global institutions, addressing public health challenges like paragonimiasis and fasciolosis. His work integrates field studies, lab-based molecular techniques, and computational biology to unravel evolutionary dynamics and ecological adaptations. Recent studies focus on the genetic diversity of Daphnia species, dugong population genetics, and drug-resistant Mycobacterium tuberculosis. His publications in journals like *Parasitology*, *Molecular Phylogenetics and Evolution*, and *Scientific Reports* highlight interdisciplinary approaches to parasitology and conservation biology.

• Parasitology
• Molecular Biology
• Phylogenetics
• +5 more

Dist. Professor Rachel Caruso is a Professor at RMIT University's School of Science, specializing in nanomaterials, energy storage systems, and photocatalysis. Her research focuses on advancing materials science through innovations in titanium-based nanomaterials, perovskite solar cells, and sustainable hydrogen production. She is actively involved in research supervision, offering guidance on topics like carbon capture, electrochemical CO₂ reduction, and antimicrobial surface engineering. Her work integrates machine learning for material discovery and emphasizes interdisciplinary applications in environmental and biomedical fields. Research Interests: Macromolecular Chemistry, Nanotechnology, Energy Materials, Photocatalysis, and Biomedical Applications. Supervision Projects: Includes pioneering studies on direct air capture of CO₂, graphene-based photocatalytic films, and perovskite materials for biomedical uses. Professor Caruso collaborates extensively on projects addressing global challenges such as renewable energy and antimicrobial resistance. Her contributions span over 200 publications, with notable advancements in titanium suboxide synthesis and electrocatalyst design.

• Macromolecular and Materials Chemistry
• Physical Chemistry (incl. Structural)
• Nanotechnology
• +3 more

JIANG Xingyu is Chair Professor and Head of the Department of Biomedical Engineering at the Southern University of Science and Technology (SUSTech) . Since 2018 he has led a multidisciplinary team developing advanced micro- and nano-scale tools for analytical chemistry, microfluidics and nanomedicine. Education Postdoctoral Research, Harvard University (2004–2005) Ph.D. in Chemistry, Harvard University (2004) B.S. in Chemistry, University of Chicago (1999) Research Interests Professor Jiang’s research integrates analytical chemistry , microfluidics , biomedical engineering and nanomedicine . His laboratory designs microfluidic chips for point-of-care diagnostics, engineers gold nanoclusters and nanoparticles for antimicrobial and anticancer therapy, and develops soft flexible bio-electronics for neural interfaces and wearable health monitoring. Across 400+ publications, recent work demonstrates a clear trend toward translational nanomedicine : point-of-care viral variant detection, nanoantibiotic strategies against multidrug-resistant bacteria, CRISPR delivery systems for cancer therapy, and conformal electronic tattoos for human-machine interfaces. Scientific Awards & Honours Fellow, American Institute for Medical and Biological Engineering (2020) Fellow, Royal Society of Chemistry (2016) Tencent Science Exploration Award (2019) Chief Scientist, National Key R&D Program (2019–) National Science Fund for Distinguished Young Scholars (2010) Young Investigator Award, Human Frontier Science Program (2007) Research Funding & Teams He currently directs the Nanoscience Laboratory at SUSTech, hosts National Key R&D Program projects as Chief Scientist, and serves on editorial boards of Advanced Healthcare Materials , Lab on a Chip , Nanoscale Horizons , Nanoscale and Nanoscale Advances . The group is actively recruiting post-docs, research professors and technicians across chemistry, materials, biology and medical engineering disciplines.

• Analytical Chemistry
• Microfluidics
• Biomedical Engineering
• +2 more

Lawrence Goodridge is a Professor and Director of the Canadian Research Institute for Food Safety (CRIFS) at the University of Guelph's Ontario Agricultural College. He holds the Leung Family Professorship in Food Safety and leads research at the intersection of food safety, antibiotic resistance, and One Health principles. His work focuses on applying genomic technologies to study foodborne pathogens (E. coli, Salmonella, Listeria, Cronobacter) and leveraging wastewater surveillance for infectious disease outbreak prediction. Academic History: BSc Microbiology (University of Guelph, 1995), MSc Food Microbiology (2003), PhD Food Microbiology (2002), followed by post-doctoral training in Food Safety at the University of Georgia (2002). Joined CRIFS in 2003. Research Interests: Genomic analysis of pathogen emergence, wastewater-based epidemiology, bacteriophage applications, and consumer education strategies for food safety. His lab develops innovative methods for rapid pathogen detection in food systems and environmental samples. Articles Trends: Over 100 peer-reviewed publications emphasize genomic surveillance of foodborne pathogens and SARS-CoV-2, with a focus on wastewater sampling innovations. Recent work explores multi-modal data integration for public health forecasting and ethical data protection frameworks for surveillance programs. Awards: While no specific prizes are listed, his $50M+ research funding from Canadian/international sources underscores recognition of his impactful work. Grants support projects like phage-based sanitization and antimicrobial resistance tracking. Advising & Labs: Leads CRIFS laboratory operations and collaborates globally on food safety initiatives. His research has informed food industry guidelines and policy frameworks for mitigating pathogen risks in agricultural and environmental systems.

• Food Safety
• Antibiotic Resistance
• Foodborne Pathogens
• +6 more

Joel Weadge is an Associate Professor in the Biology Department at Wilfrid Laurier University , Waterloo, Ontario. His research focuses on bacterial biofilms, glycobiology, and protein structure-function relationships. Contact: jweadge@wlu.ca , Office: BA425 (Bricker Academic). Education: PhD in Microbiology (University of Guelph, 2006) BSc (Hons) in Microbiology (University of Guelph, 2000) Research Interests center on bacterial biofilms as virulence factors in pathogens like E. coli and Salmonella . Key areas include: Structural and functional characterization of biofilm proteins (cellulose, curli fimbriae) Enzymology of carbohydrate modifications (acetylation, phosphoethanolamine transfer) Developing therapeutics targeting biofilm synthesis Biopolymer applications for medical/industrial use Publications highlight studies on Pseudomonas and Salmonella biofilm mechanisms, glycosyltransferases, and carbohydrate-active enzymes, with methodologies spanning X-ray crystallography to high-throughput biofilm profiling. Labs and Teams: The Weadge Lab investigates biofilm roles in food/water security and oral health, utilizing enzymology, mass spectrometry, and structural biology. Current members include graduate students, technicians, and research assistants.

• Bacterial Biofilms
• Bacterial Carbohydrates
• Protein Structure and Function
• +7 more

Qing Cao is an Associate Professor of Materials Science and Engineering at the University of Illinois at Urbana-Champaign, with courtesy appointments in Chemistry and Electrical Engineering. He leads the Cao Research Group within the Grainger College of Engineering and serves as Deputy Editor of Science Advances. Dr. Cao received his B.S. in Chemistry from Nanjing University in 2004 and his Ph.D. in Materials Chemistry from the University of Illinois at Urbana-Champaign in 2009. After working for 9 years as a research scientist at IBM Thomas J. Watson Research Center, he returned to UIUC in 2018 as a faculty member. His research focuses on developing functional nanomaterials for unconventional electronic systems, high-performance logic devices, and low-cost energy harvesting. The Cao Research Group specifically works on: nanoelectronic devices based on novel nanomaterials; next-generation memory devices for neuromorphic and in-memory computing; monolithic 3D integration for high performance electronics; high-performance printable electronic materials; and bioelectronics for healthcare applications. His work bridges materials science, chemistry, electrical engineering, and device physics. Analysis of Dr. Cao's recent publications reveals a strong focus on electrochemical memory devices for neuromorphic computing, with significant work on carbon nanotube-based electronics and novel nanomaterials. His 2023 Nature Electronics paper on CMOS-compatible electrochemical synaptic transistors demonstrates his leadership in developing hardware solutions for deep learning acceleration. His research trajectory shows a progression from fundamental carbon nanotube device physics to more applied systems for computing and sensing applications. IBM Pat Goldberg Memorial Best Paper Award (2017) IBM Master Inventor Award (2016) MIT Technology Review TR35 (2016) Forbes '30 Under 30' (2012) and 'Most Influential All-Star Alumni' (2016) Atlantic Council Millennium Fellow (2017) US Frontiers of Engineering by National Academy of Engineering (2016, 2019) 17 IBM Invention Achievement Awards (2011-2018) Dr. Cao has secured significant research funding including NSF grants 1950182 and 2139185. His research group actively recruits graduate students and postdoctoral researchers to work on cutting-edge materials and device projects. His work has resulted in over thirty research papers and fifty patents and patent applications. He teaches graduate courses including MSE 403 (Synthesis of Materials), MSE 460 (Electronic Materials I), and MSE 488 (Optical Materials). The Cao Research Group operates within the University of Illinois' world-class facilities including the Frederick Seitz Materials Research Laboratory and Holonyak Micro and Nanotechnology Laboratory. His research has received support from NSF, DoD, DOE, and industry partners including TSMC. The group's recent $2 million project focuses on developing technology to help mobile devices learn and adapt to their surroundings.

• Nanomaterials
• Electronic Devices
• Optoelectronic Devices
• +5 more

Prof. Raul Fangueiro is a Full Professor and Vice-Dean at the School of Engineering, University of Minho, Portugal. As a Senior Researcher, he leads FIBRENAMICS – Institute of Innovation on Fiber-Based Materials and Composites. His work spans advanced materials (nano, smart, composites) and structures (3D, auxetic, multiscale) with applications in defense, healthcare, construction, and automotive sectors. Supervised over 20 PhD and Post-Doc researchers Scientific coordinator of 20+ national/international research projects Author of 200+ journal papers (H-index: 47), 500+ conference publications, 36 books, 40 patents Research focuses on nanotechnology , electrospinning , and sustainable material systems : Auxetic composites for personal protection Biodegradable nanofibers for medical use Smart textiles for biological/chemical resistance Recycled mineral/wood-based composites Graphene-reinforced green materials Multiscale fiber architectures Scientific recognition includes: Top 2% most influential scientist (Elsevier/Stanford 2020) Founder of AUXDEFENSE and ICNF conferences Editorial board member of leading composite journals Advisor to European Defense Agency/NATO working groups Active in industry-academia partnerships through spin-offs (Sciencentris, B4Logic, Beyond Composites, Givaware, Pixartidea) and collaborative projects with institutions like Instituto Superior Técnico, University of Aveiro, and international universities.

• Advanced Materials
• Composite Materials
• Smart Materials
• +8 more

John E. Moses is a Professor at Cold Spring Harbor Laboratory (CSHL), where he leads the Moses Laboratory and serves as Faculty Head of the Mass Spectrometry Shared Resource for the Cancer Center. He is also a Cancer Center Member focusing on developing chemical tools for biological discovery, particularly in cancer research. Dr. Moses earned his D.Phil. in Synthetic Organic Chemistry from the University of Oxford in 2004. His academic journey includes positions as Professor of Organic Chemistry at La Trobe University (2017-2020), Level 6 Future Fellow at the Australian Research Council (2017-2021), and Reader & Associate Professor in Organic Chemistry at the University of Nottingham (2007-2017). Moses' research focuses on click chemistry, a powerful discovery method that uses robust chemical reactions to synthesize functional molecules. His lab specializes in developing and exploiting bond-forming click reactions for rapid synthesis of small functional molecules, including cancer drugs and chemical probes. They apply these molecular tools in multidisciplinary projects spanning biology and chemistry. His recent work has led to significant advances in click chemistry methodologies, including Diversity Oriented Clicking (DOC) and Phosphorus Fluoride Exchange (PFEx). These approaches have enabled the discovery of new cancer therapeutics and antibiotics effective against multidrug-resistant bacteria like MRSA. Dr. Moses has received numerous honors including the 2021 Organic Division Horizon Prize: Robert Robinson Award in Synthetic Organic Chemistry, Fellow of the Royal Society of Chemistry (2015), Thieme Chemistry Award (2011), and UK & ROI Lilly Award for Excellence in Organic Chemistry (2011). Through his work at CSHL, Moses mentors students and postdoctoral researchers while collaborating with biologists to develop Chemistry For Biology. His lab's innovative approaches have been supported by multiple grants, including those from the National Cancer Institute. The Moses Laboratory is at the forefront of click chemistry research, developing new methodologies while applying them to solve critical problems in cancer biology and antibiotic resistance.

• Click Chemistry
• Cancer Drug Development
• Antibiotic Discovery
• +4 more